Leading nanotech company, Curran Biotech has developed Capture Coating for ordinary air filters. The revolutionary new nanocoating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters.

Capture Coating is protecting work environments and public gathering spaces, correctional facilities, hospitals, school districts, and universities. With the success of the introduction of the coated air filters, Curran Biotech announces distribution throughout North America and Western Europe.

"We are addressing the need for getting Capture Coating to as many people as we can, as quickly as possible," says Professor Shay Curran, Curran Biotech founder. "Our coating establishes a permanent, water-repellent, antiviral barrier on the air filter in your home or office. In fact, it enables less expensive filters rated as MERV 8 to perform better than MERV 13 without a dramatic change in filter expense or installation of new capital equipment."

According to the company release, It has been independently tested and has been found to transform everyday air filters into a viral fighting front-line tool in the battle against Covid-19, stopping the virus, variants, and other aqueous airborne contagions at the air filter within HVAC heating and cooling systems.